{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:41:11Z","timestamp":1790692871917,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370254"],"award-info":[{"award-number":["81370254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11011-018-0293-4","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T01:38:06Z","timestamp":1532137086000},"page":"1869-1875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Oxymatrine attenuates brain hypoxic-ischemic injury from apoptosis and oxidative stress: role of p-Akt\/GSK3\u03b2\/HO-1\/Nrf-2 signaling pathway"],"prefix":"10.1007","volume":"33","author":[{"given":"Xu-Hua","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,21]]},"reference":[{"issue":"7","key":"293_CR1","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1007\/s12035-017-0798-6","volume":"55","author":"Tahir Ali","year":"2017","unstructured":"Ali T, Kim T, Rehman SU, Khan MS, Amin FU, Khan M, Ikram M, Kim MO (2017) Natural dietary supplementation of anthocyanins via PI3K\/Akt\/Nrf2\/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alzheimer's disease. Mol Neurobiol 55(7):6076\u20136093","journal-title":"Molecular Neurobiology"},{"key":"293_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","volume":"157","author":"I Buendia","year":"2016","unstructured":"Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Leon R (2016) Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84\u2013104","journal-title":"Pharmacol Ther"},{"key":"293_CR3","first-page":"4919","volume":"14","author":"S Cao","year":"2017","unstructured":"Cao S, Du J, Hei Q (2017) Lycium barbarum polysaccharide protects against neurotoxicity via the Nrf2-HO-1 pathway. Exp Ther Med 14:4919\u20134927","journal-title":"Exp Ther Med"},{"key":"293_CR4","first-page":"10420","volume":"8","author":"L Cheng","year":"2015","unstructured":"Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S (2015) Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2\/ARE pathway. Int J Clin Exp Med 8:10420\u201310428","journal-title":"Int J Clin Exp Med"},{"key":"293_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1179\/016164110X12759951866876","volume":"33","author":"L Cui","year":"2011","unstructured":"Cui L, Zhang X, Yang R, Wang L, Liu L, Li M, Du W (2011) Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats. Neurol Res 33:319\u2013324","journal-title":"Neurol Res"},{"key":"293_CR6","doi-asserted-by":"publisher","first-page":"704706","DOI":"10.1155\/2009\/704706","volume":"2009","author":"H Fan","year":"2009","unstructured":"Fan H, Li L, Zhang X, Liu Y, Yang C, Yang Y, Yin J (2009) Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia. Mediat Inflamm 2009:704706","journal-title":"Mediat Inflamm"},{"key":"293_CR7","first-page":"277","volume":"21","author":"M He","year":"2011","unstructured":"He M, Siow RC, Sugden D, Gao L, Cheng X, Mann GE (2011) Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis 21:277\u2013285","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"293_CR8","first-page":"110","volume":"11","author":"Y Hu","year":"2017","unstructured":"Hu Y, Zhan Q, Zhang H, Liu X, Huang L, Li H, Yuan Q (2017) Increased susceptibility to ischemic brain injury in Neuroplastin 65-deficient mice likely via glutamate excitotoxicity. Front Cell Neurosci 11:110","journal-title":"Front Cell Neurosci"},{"key":"293_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1590\/S0102-865020150060000008","volume":"30","author":"G Jiang","year":"2015","unstructured":"Jiang G, Liu X, Wang M, Chen H, Chen Z, Qiu T (2015) Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2\/HO-1 pathway. Acta Cir Bras 30:422\u2013429","journal-title":"Acta Cir Bras"},{"key":"293_CR10","first-page":"1532","volume":"21","author":"LJ Jiang","year":"2017","unstructured":"Jiang LJ, Zhang SM, Li CW, Tang JY, Che FY, Lu YC (2017) Roles of the Nrf2\/HO-1 pathway in the anti-oxidative stress response to ischemia-reperfusion brain injury in rats. Eur Rev Med Pharmacol Sci 21:1532\u20131540","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"293_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.redox.2017.04.006","volume":"12","author":"U Kilic","year":"2017","unstructured":"Kilic U, Caglayan AB, Beker MC, Gunal MY, Caglayan B, Yalcin E, Kelestemur T, Gundogdu RZ, Yulug B, Yilmaz B, Kerman BE, Kilic E (2017) Particular phosphorylation of PI3K\/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice. Redox Biol 12:657\u2013665","journal-title":"Redox Biol"},{"key":"293_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1248\/bpb.34.595","volume":"34","author":"M Li","year":"2011","unstructured":"Li M, Zhang X, Cui L, Yang R, Wang L, Liu L, Du W (2011) The neuroprotection of oxymatrine in cerebral ischemia\/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of nrf2 and hemeoxygenase-1 expression. Biol Pharm Bull 34:595\u2013601","journal-title":"Biol Pharm Bull"},{"key":"293_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2009.02.069","volume":"1268","author":"Y Liu","year":"2009","unstructured":"Liu Y, Zhang XJ, Yang CH, Fan HG (2009) Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. Brain Res 1268:174\u2013180","journal-title":"Brain Res"},{"key":"293_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/ptr.5632","volume":"30","author":"ML Lu","year":"2016","unstructured":"Lu ML, Xiang XH, Xia SH (2016) Potential signaling pathways involved in the clinical application of Oxymatrine. Phytother Res 30:1104\u20131112","journal-title":"Phytother Res"},{"key":"293_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000085978","volume":"27","author":"RC Vannucci","year":"2005","unstructured":"Vannucci RC, Vannucci SJ (2005) Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 27:81\u201386","journal-title":"Dev Neurosci"},{"key":"293_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/10715762.2015.1136411","volume":"50","author":"X Zhai","year":"2016","unstructured":"Zhai X, Lin H, Chen Y, Chen X, Shi J, Chen O, Li J, Sun X (2016) Hyperbaric oxygen preconditioning ameliorates hypoxia-ischemia brain damage by activating Nrf2 expression in vivo and in vitro. Free Radic Res 50:454\u2013466","journal-title":"Free Radic Res"},{"key":"293_CR17","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s13277-013-1223-z","volume":"35","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao Z, Sun H, Ding Y (2014) Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG\/HOS cells through inhibition of PI3K\/Akt pathway. Tumour Biol 35:1619\u20131625","journal-title":"Tumour Biol"},{"key":"293_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuint.2015.06.008","volume":"89","author":"P Zhao","year":"2015","unstructured":"Zhao P, Zhou R, Li HN, Yao WX, Qiao HQ, Wang SJ, Niu Y, Sun T, Li YX, Yu JQ (2015) Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death. Neurochem Int 89:17\u201327","journal-title":"Neurochem Int"},{"key":"293_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4077\/CJP.2017.BAF434","volume":"60","author":"SM Zhao","year":"2017","unstructured":"Zhao SM, Gao HL, Wang YL, Xu Q, Guo CY (2017) Attenuation of high glucose-induced rat cardiomyocyte apoptosis by Exendin-4 via intervention of HO-1\/Nrf-2 and the PI3K\/AKT signaling pathway. Chin J Phys 60:89\u201396","journal-title":"Chin J Phys"},{"key":"293_CR20","doi-asserted-by":"publisher","first-page":"26859","DOI":"10.1038\/srep26859","volume":"6","author":"H Zhu","year":"2016","unstructured":"Zhu H, Zhang Y, Shi Z, Lu D, Li T, Ding Y, Ruan Y, Xu A (2016) The neuroprotection of Liraglutide against Ischaemia-induced apoptosis through the activation of the PI3K\/AKT and MAPK pathways. Sci Rep 6:26859","journal-title":"Sci Rep"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0293-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T21:37:23Z","timestamp":1569101843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0293-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,21]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0293-4","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,21]]},"assertion":[{"value":"8 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of conflicting interests"}}]}}